Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Samsung Electronics (005930) – Other Management Matters (Voluntary Disclosure) / 2025-02-18

Posted on February 18, 2025July 29, 2026 By K-STOCK Editor No Comments on [Disclosure] Samsung Electronics (005930) – Other Management Matters (Voluntary Disclosure) / 2025-02-18

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Samsung Electronics has decided to sponsor WorldSkills International (WSI) with EUR 1.65M (approx. KRW 2.43B) to support future technical talent and corporate social responsibility initiatives.

📊 [Key Disclosure Details & Financial Summary]

  • Disclosure Title: Sponsorship for WorldSkills
  • Purpose: Promoting global corporate social responsibility to nurture future technical talent for global industrial development
  • Recipient Organization: WorldSkills International (WSI)
  • Sponsorship Details:
    1. Sponsorship for the 48th WorldSkills Competition in Shanghai, China
    2. Institutional sponsorship for WorldSkills International (WSI)
  • Sponsorship Amount: EUR 1,650,000 (Approx. KRW 2,430,000,000 / KRW 2.43B)
  • Scheduled Payout Date: March 2025
  • Decision (Board Resolution) Date: February 18, 2025

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Sponsorship Payment and Reflection in Periodic Reports

This disclosure reports a voluntary contribution of EUR 1.65M (approx. KRW 2.43B) to WorldSkills International and the 48th Shanghai competition. Verifying whether the sponsorship payment is executed as scheduled in March 2025 is important for tracking the implementation of this disclosure. Detailed records can be verified in future periodic business reports or relevant follow-up disclosures.

📢 Disclaimer & Source Information

Source: This content was newly structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial liabilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Samsung Electronics (005930) – Other Management Matters (Voluntary Disclosure) / 2025-02-18
Next Post: [Disclosure] Samsung Electronics (005930) – Submission of Audit Report / 2025-02-18

Related Posts

[Disclosure] Hana Micron (067310) – Securities Issuance Results (Voluntary Disclosure) / 2024-08-06 Semiconductors
[Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2025-02-19 Disclosures
[Disclosure] SK Square (402340) – Change of Listing / 2025-01-16 Semiconductors
[Disclosure] Samsung Biologics (207940) – Submission of Audit Report / 2024-02-28 Disclosures
[Disclosure] SK Square (402340) – Decision on Disposal of Treasury Shares / 2025-01-23 Semiconductors
[Disclosure] Hanwha Aerospace (012450) Subsidiary Hanwha Ocean USA International LLC Finalizes Capital Increase with Payment Date Confirmed for August 30, 2025 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme